Melatonin Treatment in Kidney Diseases
Cells · 08.03.2023 · 12 (6) · 838
DOI: 10.3390/cells12060838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 08.03.2023. Verfasst von Magdalena Markowska und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaserów Street, 04-141 Warsaw, Poland. Hauptthemen laut MEDLINE: Melatonin, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melatonin is a neurohormone that is mainly secreted by the pineal gland. It coordinates the work of the superior biological clock and consequently affects many processes in the human body. Disorders of the waking and sleeping period result in nervous system imbalance and generate metabolic and endocrine derangements. The purpose of this review is to provide information regarding the potential benefits of melatonin use, particularly in kidney diseases. The impact on the cardiovascular system, diabetes, and homeostasis causes melatonin to be indirectly connected to kidney function and quality of life in people with chronic kidney disease. Moreover, there are numerous reports showing that melatonin plays a role as an antioxidant, free radical scavenger, and cytoprotective agent. This means that the supplementation of melatonin can be helpful in almost every type of kidney injury because inflammation, apoptosis, and oxidative stress occur, regardless of the mechanism. The administration of melatonin has a renoprotective effect and inhibits the progression of complications connected to renal failure. It is very important that exogenous melatonin supplementation is well tolerated and that the number of side effects caused by this type of treatment is low.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Diseases, Nephrology and Dialysis, Military Institute of Medicine, 128 Szaserów Street, 04-141 Warsaw, Poland.
ORCID-Profile: Magdalena Markowska, Katarzyna Romejko
Zitieren
APA
Markowska, M., Niemczyk, S., & Romejko, K. (2023). Melatonin Treatment in Kidney Diseases. Cells, 12(6), 838. https://doi.org/10.3390/cells12060838
Vancouver
Markowska M, Niemczyk S, Romejko K. Melatonin Treatment in Kidney Diseases. Cells. 2023;12(6):838. doi:10.3390/cells12060838
BibTeX
@article{Markowska2023,
author = {Markowska, Magdalena and Niemczyk, Stanisław and Romejko, Katarzyna},
title = {Melatonin Treatment in Kidney Diseases},
journal = {Cells},
year = {2023},
volume = {12},
number = {6},
pages = {838},
doi = {10.3390/cells12060838}
}
EUVIMED